Skip to main content

Peer Review reports

From: Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan

Original Submission
10 Aug 2017 Submitted Original manuscript
31 Aug 2017 Reviewed Reviewer Report - Hideki Hashimoto
11 Sep 2017 Reviewed Reviewer Report - Frank G. A. Jansman
5 Oct 2017 Author responded Author comments - Muhammad Rehan Sarwar
Resubmission - Version 2
5 Oct 2017 Submitted Manuscript version 2
17 Oct 2017 Reviewed Reviewer Report - Frank G. A. Jansman
29 Oct 2017 Reviewed Reviewer Report - Hideki Hashimoto
16 Nov 2017 Author responded Author comments - Muhammad Rehan Sarwar
Resubmission - Version 3
16 Nov 2017 Submitted Manuscript version 3
4 Dec 2017 Author responded Author comments - Muhammad Rehan Sarwar
Resubmission - Version 4
4 Dec 2017 Submitted Manuscript version 4
14 Dec 2017 Author responded Author comments - Muhammad Rehan Sarwar
Resubmission - Version 5
14 Dec 2017 Submitted Manuscript version 5
Publishing
22 Dec 2017 Editorially accepted
3 Jan 2018 Article published 10.1186/s12885-017-3980-3

You can find further information about peer review here.

Back to article page